LTRN icon

Lantern Pharma
LTRN

Overview Fund Activity

30 hedge funds and large institutions have $4.95M invested in Lantern Pharma in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 13 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
30
Holders Change
+3
Holders Change %
+11.11%
% of All Funds
0.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
6
Reduced
13
Closed
–
Calls
$10K
Puts
$2K
Net Calls
+$8K
Net Calls Change
+$23K

Top Buyers

1
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
$252K
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
$50.6K
3
Renaissance Technologies
Renaissance Technologies
New York
$187K
4
CM
CM Management
Florida
$342K
5
MWM
Meridian Wealth Management
Kentucky
$84.1K

Top Sellers

1
CC
Carlson Capital
Texas
$257K
2
SPC
Sigma Planning Corp
Michigan
$50.8K
3
RAM
Redmond Asset Management
Virginia
$174K
4
Citadel Advisors
Citadel Advisors
Florida
$106K
5
PFA
Pathway Financial Advisors
Vermont
$122K
Name Holding Trade Value Shares
Change 		Shares
Change %
AF
26
Allworth Financial
California
$428 – – –
JPMorgan Chase & Co
27
JPMorgan Chase & Co
New York
$56 +$17 +4 +44%
Bank of America
28
Bank of America
North Carolina
$21 +$21 +5 New
Qube Research & Technologies (QRT)
29
Qube Research & Technologies (QRT)
United Kingdom
$9 – – –
1
2